🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the China Extension study is to assess the safety and effica...
Status
Completed
Location
Beijing Cancer Hospital (0601)
Start Date
2020-07-14
Trial ID
NCT04889118
Treatments Being Tested
This is a prospective, randomized, placebo-controlled, double-blind, multic...
Status
Active Not Recruiting
Location
Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command
Start Date
2020-06-29
Trial ID
NCT04523493
Treatments Being Tested
A study to evaluate cadonilimab (AK104) + lenvatinib in combination with tr...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2024-08-02
Trial ID
NCT06371157
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pemetrexe...
Status
Completed
Location
Peking Union Medical College Hospital ( Site 0108)
Start Date
2019-11-05
Trial ID
NCT04716933
Treatments Being Tested
To evaluate the additional efficacy and safety of oral enterobacterial caps...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-30
Trial ID
NCT06563934
The purpose of this study is to evaluate the safety and efficacy of lenvati...
Status
Completed
Location
The University of Arizona Cancer Center - North Campus ( Site 0621)
Start Date
2018-12-31
Trial ID
NCT03713593
Treatments Being Tested
This is a Phase III, prospective, randomized, three-arm, double-blind, plac...
Status
Recruiting
Location
Zhongshan Hospital affiliated to Fudan University
Start Date
2023-06-19
Trial ID
NCT05342194
This is a study of pembrolizumab (MK-3475) with or without lenvatinib (E708...
Status
Completed
Location
California Cancer Associates for Research & Excellence ( Site 0025)
Start Date
2020-02-05
Trial ID
NCT04199104
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) with or without lenvatinib (E708...
Status
Completed
Location
Anhui Cancer Hospital-Radiology Department ( Site 3333)
Start Date
2020-10-30
Trial ID
NCT05523323
Treatments Being Tested
This is a Phase 2b, randomized, blinded clinical trial investigating the ef...
Status
Recruiting
Location
USC Norris Comprehensive Cancer Center
Start Date
2026-03-19
Trial ID
NCT07219459
Treatments Being Tested